Cryosite Limited (ASX:CTE) is an Australian company specialising in temperature-controlled storage and logistics solutions for the life sciences and pharmaceutical industries, in particular for clinical trials and biological materials. CTE has released a Q1 FY26 trading update which demonstrated strong financial and operational performance for the quarter. The customer base seems to be increasing with existing clients expanding their work with CTE while new clients have been onboarded in recent months. The company’s newly-acquired freehold warehouse facility in Auburn, NSW announced earlier this month is well-timed to capture the increase in demand that CTE is experiencing. Interestingly, additional commentary on CTE’s legacy Cord Blood business points to strong cash generation in the years ahead, something that is perhaps underappreciated by the market.